SCHEMBL23224978

SCHEMBL23224978

CC1(C)c2ccccc2-c2ccc(N(c3ccc(-c4cc5ccccc5c5ccccc45)cc3)c3cccc(-c4cccc5ccccc45)c3)cc21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB4 P30926 2/20 0.34
CHRNA3 P32297 2/20 0.34
CHRNA1 P02708 1/20 0.34
CHRNG P07510 1/20 0.34
CHRNB1 P11230 1/20 0.34
CHRNB2 P17787 1/20 0.34
SLC6A2 P23975 1/20 0.34
SLC6A4 P31645 1/20 0.34
CHRNA4 P43681 1/20 0.34
SLC6A3 Q01959 1/20 0.34
CHRND Q07001 1/20 0.34
MCL1 Q07820 1/20 0.34
ACMSD Q8TDX5 1/20 0.34
CA12 O43570 3/20 0.33
CA1 P00915 3/20 0.33
CA2 P00918 3/20 0.33
CA9 Q16790 3/20 0.33
CYP11B1 P15538 1/20 0.32
ENPP3 O14638 1/20 0.32
ENPP1 P22413 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23447761 1.00 CHRNB4 (0.34) CHRNB4CHRNA3CHRNA1CHRNGCHRNB1
SCHEMBL23238986 0.98 CA12 (0.34) CHRNB4CHRNA3CHRNA1CHRNGCHRNB1
SCHEMBL23447826 0.97 CHRNA1 (0.36) CHRNB4CHRNA3CHRNA1CHRNGCHRNB1
SCHEMBL23472053 0.97 CYP11B1 (0.34) CYP11B1ALDH1A1HPGDKDM4EMEN1
SCHEMBL23224951 0.96 CA12 (0.37) CHRNB4CHRNA3CHRNA1CHRNGCHRNB1
SCHEMBL23447766 0.96 CA12 (0.37) CHRNB4CHRNA3CHRNA1CHRNGCHRNB1
SCHEMBL20102237 0.96 MCL1 (0.34) CHRNB4CHRNA3CHRNA1CHRNGCHRNB1
SCHEMBL23237744 0.95 CA12 (0.36) CHRNB4CHRNA3CHRNA1CHRNGCHRNB1
SCHEMBL23447780 0.95 CA12 (0.35) CHRNB4CHRNA3CHRNA1CHRNGCHRNB1
SCHEMBL23239391 0.95 CA12 (0.37) CHRNB4CHRNA3CHRNA1CHRNGCHRNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230024273-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-01-26 US disclosed
US-20230002420-A1 ORGANIC LIGHT-EMITTING ELEMENT LG CHEM, LTD. (KR) 2023-01-05 US disclosed
WO-2021107737-A1 ORGANIC LIGHT-EMITTING ELEMENT 주식회사 엘지화학 2021-06-03 WO disclosed
WO-2021070965-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE 出光興産株式会社 2021-04-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230002420-A1 ORGANIC LIGHT-EMITTING ELEMENT CYBA, CRY1, CYP1A1 CHRNB4 2107/4885CHRNA3 1846/4885CHRNA1 359/4885
US-20230024273-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE LEF1, L1CAM, PIEZO1 CHRNB4 3101/4885CHRNA3 3519/4885CHRNA1 2805/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.